SXTC Stock Overview
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
China SXT Pharmaceuticals, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.03 |
52 Week High | US$9.38 |
52 Week Low | US$0.94 |
Beta | 1.03 |
1 Month Change | -38.69% |
3 Month Change | -44.02% |
1 Year Change | -79.09% |
3 Year Change | -99.86% |
5 Year Change | -99.99% |
Change since IPO | -99.99% |
Recent News & Updates
Shareholder Returns
SXTC | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 4.0% | -0.6% | 1.0% |
1Y | -79.1% | 10.6% | 21.9% |
Return vs Industry: SXTC underperformed the US Pharmaceuticals industry which returned 13.2% over the past year.
Return vs Market: SXTC underperformed the US Market which returned 24.9% over the past year.
Price Volatility
SXTC volatility | |
---|---|
SXTC Average Weekly Movement | 19.2% |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SXTC's share price has been volatile over the past 3 months.
Volatility Over Time: SXTC's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 78 | Albert Zhou | www.sxtchina.com |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands.
China SXT Pharmaceuticals, Inc. Fundamentals Summary
SXTC fundamental statistics | |
---|---|
Market cap | US$749.69k |
Earnings (TTM) | -US$14.14m |
Revenue (TTM) | US$1.70m |
0.4x
P/S Ratio-0.1x
P/E RatioIs SXTC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SXTC income statement (TTM) | |
---|---|
Revenue | US$1.70m |
Cost of Revenue | US$1.08m |
Gross Profit | US$624.93k |
Other Expenses | US$14.76m |
Earnings | -US$14.14m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -19.42 |
Gross Margin | 36.70% |
Net Profit Margin | -830.10% |
Debt/Equity Ratio | 65.2% |
How did SXTC perform over the long term?
See historical performance and comparison